{"DataElement":{"publicId":"6423784","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Cancer Additional Pathologic Finding Type","preferredDefinition":"Text term to identify additional pathologic findings identified in a patient.","longName":"ADDTL_PATH_FINDINGS","context":"OCG","contextVersion":"1","DataElementConcept":{"publicId":"6423675","version":"1","preferredName":"Liver and Intrahepatic Bile Duct Carcinoma Additional Pathologic Finding Identification","preferredDefinition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma._Added; extra; further._Caused by or altered by or manifesting disease or pathology._Clinical, laboratory or molecular evidence, or absence of evidence of disease._The procedure of having an identity established.","longName":"3179609v1.0:6423721v1.0","context":"OCG","contextVersion":"1","ObjectClass":{"publicId":"3179609","version":"1","preferredName":"Liver and Intrahepatic Biliary Tract Carcinoma","preferredDefinition":"A disease in which malignant (cancer) cells are found in the tissues of the liver.","longName":"C7927","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Liver and Intrahepatic Bile Duct Carcinoma","conceptCode":"C7927","definition":"A carcinoma that arises from the hepatocytes or intrahepatic bile ducts.  The main subtypes are hepatocellular carcinoma (hepatoma) and cholangiocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"98A7B501-CBB5-2349-E040-BB89AD430DBA","latestVersionIndicator":"Yes","beginDate":"2010-12-30","endDate":null,"createdBy":"WHITES","dateCreated":"2010-12-30","modifiedBy":"ONEDATA","dateModified":"2010-12-30","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"6423721","version":"1","preferredName":"Additional Pathologic Finding Identification","preferredDefinition":"Added; extra; further.:Caused by or altered by or manifesting disease or pathology.:Clinical, laboratory or molecular evidence, or absence of evidence of disease.:The procedure of having an identity established.","longName":"C25406:C25610:C3367:C25737","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Additional","conceptCode":"C25406","definition":"Added; extra; further.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"3"},{"longName":"Pathologic","conceptCode":"C25610","definition":"Caused by or altered by or manifesting disease or pathology.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Finding","conceptCode":"C3367","definition":"Clinical, laboratory or molecular evidence, or absence of evidence of disease.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Identification","conceptCode":"C25737","definition":"The procedure of having an identity established.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520AF04-2EDF-0973-E053-F662850AC1CF","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"750FCE63-D586-3A70-E053-F662850A57BC","latestVersionIndicator":"Yes","beginDate":"2018-09-04","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-04","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer CDE request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"6423722","version":"1","preferredName":"Liver and Bile Duct Cancer Pathologic Finding Type","preferredDefinition":"Something distinguishable as an identifiable class based on common qualities.","longName":"6423722v1.0","context":"OCG","contextVersion":"1","type":"Enumerated","dataType":"CHARACTER","minLength":null,"maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Other (specify)","valueDescription":"Specify Other","ValueMeaning":{"publicId":"6060199","version":"1","preferredName":"Specify Other","longName":"6060199","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"647D160E-2332-6209-E053-F662850A6311","latestVersionIndicator":"Yes","beginDate":"2018-02-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-02-05","modifiedBy":"ONEDATA","dateModified":"2018-02-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-87A6-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Biliary stones","valueDescription":"Biliary Stone","ValueMeaning":{"publicId":"6423723","version":"1","preferredName":"Biliary Stone","longName":"6423723","preferredDefinition":"The presence of one or more stones in the common bile duct. They are composed either of cholesterol or, less commonly, calcium salts and bilirubin.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Common Bile Duct Stone","conceptCode":"C34499","definition":"The presence of one or more stones in the common bile duct. They are composed either of cholesterol or, less commonly, calcium salts and bilirubin.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-87B0-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-87C9-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Primary sclerosing cholangitis","valueDescription":"Primary Sclerosing Cholangitis","ValueMeaning":{"publicId":"3210800","version":"1","preferredName":"Primary Sclerosing Cholangitis","longName":"3210800","preferredDefinition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Primary Sclerosing Cholangitis","conceptCode":"C4828","definition":"A chronic, autoimmune inflammatory liver disorder characterized by narrowing and scarring of the lumen of the bile ducts. It is often seen in patients with ulcerative colitis. Signs and symptoms include jaundice, fatigue, and malabsorption. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A1CC-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-87D3-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Chronic hepatitis","valueDescription":"Chronic Hepatitis","ValueMeaning":{"publicId":"6423725","version":"1","preferredName":"Chronic Hepatitis","longName":"6423725","preferredDefinition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Chronic Hepatitis","conceptCode":"C82978","definition":"An active inflammatory process affecting the liver for more than six months. Causes include viral infections, autoimmune disorders, drugs, and metabolic disorders.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-87E0-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-87F9-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Iron overload","valueDescription":"Iron Overload","ValueMeaning":{"publicId":"2945194","version":"1","preferredName":"Iron Overload","longName":"2945194","preferredDefinition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Iron Overload","conceptCode":"C78393","definition":"Accumulation of iron in the tissues. It may be a manifestation of an inherited disorder (e.g., hemochromatosis) or acquired (in patients with repeated blood transfusions). Symptoms include hepatomegaly, arthritis, diabetes mellitus, and bronzed skin. If untreated it has a progressive course and may lead to death.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"745580E8-4272-8FA9-E040-BB89AD433702","latestVersionIndicator":"Yes","beginDate":"2009-09-24","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-09-24","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-8803-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Steatohepatitis","valueDescription":"Nonalcoholic Steatohepatitis","ValueMeaning":{"publicId":"3210796","version":"1","preferredName":"Nonalcoholic Steatohepatitis","longName":"3210796","preferredDefinition":"Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Nonalcoholic Steatohepatitis","conceptCode":"C84445","definition":"Fatty replacement and damage to the hepatocytes not related to alcohol use. It may lead to cirrhosis and liver failure.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"9F52E161-A132-C614-E040-BB89AD4377D5","latestVersionIndicator":"Yes","beginDate":"2011-03-25","endDate":null,"createdBy":"UMLLOADER_CBM","dateCreated":"2011-03-25","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-8818-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Steatosis","valueDescription":"Steatosis","ValueMeaning":{"publicId":"3249618","version":"1","preferredName":"Steatosis","longName":"3249618","preferredDefinition":"A morphologic finding indicating intracytoplasmic fat accumulation in the liver parenchyma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Steatosis","conceptCode":"C36185","definition":"Acumulation of adipose tissue in intracytoplasmic or extracellular spaces.","evsSource":"CTCAE_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"A6D9FB96-3598-EB3C-E040-BB89AD435DB4","latestVersionIndicator":"Yes","beginDate":"2011-06-29","endDate":null,"createdBy":"COOPERM","dateCreated":"2011-06-29","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-882D-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"High-grade dysplastic nodule","valueDescription":"High Grade Liver Dysplastic Nodule","ValueMeaning":{"publicId":"6423727","version":"1","preferredName":"High Grade Liver Dysplastic Nodule","longName":"6423727","preferredDefinition":"A hepatic dysplastic nodule characterized by the presence of high grade atypical cellular changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"High Grade Liver Dysplastic Nodule","conceptCode":"C96768","definition":"A hepatic dysplastic nodule characterized by the presence of high grade atypical cellular changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-883B-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-8854-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Low-grade dysplastic nodule","valueDescription":"Low Grade Liver Dysplastic Nodule","ValueMeaning":{"publicId":"6423729","version":"1","preferredName":"Low Grade Liver Dysplastic Nodule","longName":"6423729","preferredDefinition":"A hepatic dysplastic nodule characterized by the presence of low grade atypical cellular changes.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Low Grade Liver Dysplastic Nodule","conceptCode":"C96770","definition":"A hepatic dysplastic nodule characterized by the presence of low grade atypical cellular changes.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-8861-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-887A-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Cirrhosis","valueDescription":"Cirrhosis","ValueMeaning":{"publicId":"4618018","version":"1","preferredName":"Cirrhosis","longName":"4618018","preferredDefinition":"A chronic degenerative disease of the liver characterized by parenchymal nodularity and fibrosis.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Cirrhosis","conceptCode":"C2951","definition":"A disorder characterized by replacement of the liver parenchyma with fibrous tissue and regenerative nodules. It is usually caused by alcoholism, hepatitis B, and hepatitis C. Complications include the development of ascites, esophageal varices, bleeding, and hepatic encephalopathy.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"09518164-CFAC-8FD3-E050-BB89AD433831","latestVersionIndicator":"Yes","beginDate":"2014-12-03","endDate":null,"createdBy":"COOPERM","dateCreated":"2014-12-03","modifiedBy":"SOKKERL","dateModified":"2023-10-22","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-8884-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"},{"value":"Fibrosis","valueDescription":"Fibrosis","ValueMeaning":{"publicId":"4264818","version":"1","preferredName":"Fibrosis","longName":"4264818","preferredDefinition":"The formation of fibrous tissue.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Fibrosis","conceptCode":"C3044","definition":"The formation of fibrous tissue.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F67A42EF-FCDE-5F77-E040-BB89AD433177","latestVersionIndicator":"Yes","beginDate":"2014-04-07","endDate":null,"createdBy":"REEVESD","dateCreated":"2014-04-07","modifiedBy":"COOPERM","dateModified":"2020-10-16","changeDescription":"10.16.2020 Updated definition to match current NCIt. mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"7520DCD0-888F-03F6-E053-F662850A2332","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"ONEDATA","dateModified":"2018-09-05","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2435022","version":"1","preferredName":"Disease, Disorder or Finding","preferredDefinition":"Specification of human conditions relevant to cancer. This includes observations, test results, history, and other concepts relevant to characterization of human cancer-related conditions. Non-neoplastic conditions of interest are also included.","longName":"C7057","context":"NCIP","contextVersion":"1","origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"0741B16D-87D9-26CD-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-12-06","endDate":null,"createdBy":"CURTIST","dateCreated":"2005-12-06","modifiedBy":"SBR","dateModified":"2006-12-20","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2234813","version":"1","preferredName":"Type","preferredDefinition":"Type; a subdivision of a particular kind of thing.","longName":"C25284","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Type","conceptCode":"C25284","definition":"Something distinguishable as an identifiable class based on common qualities.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Standard","id":"F970CDF6-F90E-21D3-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-06-14","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-06-14","modifiedBy":"SBR","dateModified":"2005-09-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520DCD0-878E-03F6-E053-F662850A2332","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"5806857","version":"1","longName":"HCMI (Human Cancer Models Initiative)","context":"OCG","ClassificationSchemeItems":[{"publicId":"6403794","version":"1","longName":"HCC and Bile Duct Cancer","context":"OCG"}]}],"AlternateNames":[],"ReferenceDocuments":[{"name":"Additional pathologic finding","type":"Preferred Question Text","description":"Additional pathologic finding(s)","url":null,"context":"OCG"}],"origin":"HCMI:Human Cancer Models Initiative","workflowStatus":"RELEASED","registrationStatus":"Application","id":"7520A0AC-4080-2159-E053-F662850A7609","latestVersionIndicator":"Yes","beginDate":"2018-09-05","endDate":null,"createdBy":"COOPERM","dateCreated":"2018-09-05","modifiedBy":"COOPERM","dateModified":"2018-09-07","changeDescription":"Created for HCC and Bile Duct Cancer curation request 8.16.18 mc","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}